Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

This publication has 25 references indexed in Scilit:

• High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG‐1) by the European Neuroblastoma Study Group
  Pediatric Blood & Cancer, 2004
• Consolidation Treatment With Chimeric Anti-GD2-Antibody ch14.18 in Children Older Than 1 Year With Metastatic Neuroblastoma
  Journal of Clinical Oncology, 2004
• Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma
  Bone Marrow Transplantation, 2002
• Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults
  Bone Marrow Transplantation, 2001
• Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma
  Bone Marrow Transplantation, 2001
• Neuroblastoma
  Drugs, 2000
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
  New England Journal of Medicine, 1999
• “Megatherapy” for advanced neuroblastoma—Rationale and role
  European Journal Of Cancer, 1995
• Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results
  European Journal Of Cancer, 1995
• Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
  Nature, 1984